Download this datacard
Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.7 Fte (3)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Irish Pharmaceutical Healthcare Association (IPHA)
EU Transparency Register
407098547453-30 First registered on 26 Aug 2022
Goals / Remit
Promotion of policies and public support leading to the discovery and adoption of innovative medicines in Ireland and Europe.
Main EU files targeted
The main focus of IPHA activities is targeted at European and Irish pharmaceutical legislation and policies. The main focus of our current activities in relation to European legislation and policy is the revision of the General Pharmaceutical Legislation, the Orphan Medicines Regulation and Regulation of Medicinal Products for Paediatric use. We also focus on other legislation (e.g. in relation to PFAS and the forthcoming Urban Waste Water Treatment Directive). We are keenly interested in competitiveness and health policies of the Union and as proposed and developed by the Commission.
To understand policies and proposal and to put forward our Association's perspectives on them, we seek to meet member and officials of the European Commission and of the European Parliament, and national representatives at the Council of Ministers in various formations.Address
Head Office
5-7 Clanwilliam TerraceGrand Canal Quay
Dublin D02 CC64
IRELANDEU Office
5-7 Clanwilliam TerraceGrand Canal Quay
Dublin D02 CC64
IRELANDWebsite
-
People
Total lobbyists declared
3
Employment time Lobbyists 50% 1 10% 2 Lobbyists (Full time equivalent)
0.7
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 14 Sep 2024
Name Start date End Date Mr Oliver O'CONNOR 07 Jan 2023 06 Jan 2024 Complementary Information
None
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
www.efpia.eu
www.aesgp.eu
www.ifpma.orgMember organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount vulcan consulting 100,000€ - 199,999€ Intermediaries for current year
Name vulcan consulting Closed year Costs
100,000€ - 199,999€
Other financial info
In 2022, we hired the public affairs consulting firm, Vulcan Consulting (https://vulcanconsulting.eu); 38/39 Baggot Street Lower, Dublin 2, D02 T938, Ireland) in relation to the activities described in Heading 9. We do not fully outsource this activity or our representation to the firm. They advise and work with us in carrying out that activity.
-
EU Structures
Groups (European Commission)
None declared
Groups (European Parliament)
N/A
Communication activities
Public information, conferences (online and in-person), meetings with MEPs, the European Commission and Ireland's Permanent Representation at to the EU and members of the Irish Government and officials involved in the Council of Ministers.
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 10 Feb 2023 Location Brussels Subject Discussion of upcoming pharmaceutical package; value of predictability (IP), EU pharmaceutical product approval process, competitiveness, unmet medical needs. Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Patricia Reilly (Cabinet member)
Other Lobbyists